share_log

Ocular Therapeutix | 8-K: Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results

SEC announcement ·  Mar 11 16:14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more